These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20534766)

  • 1. Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome compared with Caucasian counterparts.
    Koval KW; Setji TL; Reyes E; Brown AJ
    J Clin Endocrinol Metab; 2010 Sep; 95(9):E49-53. PubMed ID: 20534766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
    Song do K; Lee H; Sung YA; Oh JY
    Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein profiles in Mexican American and non-Hispanic white women with polycystic ovary syndrome.
    Kauffman RP; Baker TE; Graves-Evenson K; Baker VM; Castracane VD
    Fertil Steril; 2011 Dec; 96(6):1503-7. PubMed ID: 21982731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic markers, regional adiposity, and adipose cell size: relationship to insulin resistance in African-American as compared with Caucasian women.
    Allister-Price C; Craig CM; Spielman D; Cushman SS; McLaughlin TL
    Int J Obes (Lond); 2019 Jun; 43(6):1164-1173. PubMed ID: 30127463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.
    Valkenburg O; Steegers-Theunissen RP; Smedts HP; Dallinga-Thie GM; Fauser BC; Westerveld EH; Laven JS
    J Clin Endocrinol Metab; 2008 Feb; 93(2):470-6. PubMed ID: 18056772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
    Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
    J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
    Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
    Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome.
    Blum MR; Popat RA; Nagy A; Cataldo NA; McLaughlin TL
    J Endocrinol Invest; 2021 Oct; 44(10):2123-2130. PubMed ID: 33687700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
    Sam S; Scoccia B; Yalamanchi S; Mazzone T
    Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome.
    Cenk Sayin N; Gücer F; Balkanli-Kaplan P; Ali Yüce M; Yardim T
    Gynecol Endocrinol; 2003 Oct; 17(5):387-96. PubMed ID: 14710586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance?
    Kim-Dorner SJ; Deuster PA; Zeno SA; Remaley AT; Poth M
    Metabolism; 2010 Feb; 59(2):299-304. PubMed ID: 19796777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome?
    Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E
    Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The triglyceride/high-density lipoprotein cholesterol ratio fails to predict insulin resistance in African-American women: an analysis of Jackson Heart Study.
    Sumner AE; Harman JL; Buxbaum SG; Miller BV; Tambay AV; Wyatt SB; Taylor HA; Rotimi CN; Sarpong DF
    Metab Syndr Relat Disord; 2010 Dec; 8(6):511-4. PubMed ID: 20715971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in serum sex hormone and plasma lipid levels in Caucasian and African-American premenopausal women.
    Lamon-Fava S; Barnett JB; Woods MN; McCormack C; McNamara JR; Schaefer EJ; Longcope C; Rosner B; Gorbach SL
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4516-20. PubMed ID: 15886254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.
    Welt CK; Arason G; Gudmundsson JA; Adams J; Palsdóttir H; Gudlaugsdóttir G; Ingadóttir G; Crowley WF
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4361-8. PubMed ID: 16940441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
    Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.